금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Oil Drops as Tankers Begin Moving More Gulf Crude
Brent crude futures dropped for a third session as Iran and Oman advanced plans for a temporary mari...
Gold tumbles as high US inflation supports Fed hawkish bets
Gold (XAU/USD) price drops over 1.37% on Wednesday as economic data from the United States (US) broa...
Crude Oil finds the tollbooth inside the Hormuz corridor
Crude Oil trades just above $82.00 and 1.78% higher on the session, which is not where it was headin...
Atlanta Fed's GDPNow revised up to 1.7% for Q2 growth
Donegal Group declares $0.1925 dividend
Assets under management rise modestly in June despite pullback in broader market returns
AeroVironment shares gain after report of progress on Army laser weapon
U.S. Bancorp projects 2026 net revenue growth of 7%-9% with BTIG adding about $200M per quarter in H2
Global Remittance Stock Breaks Out As Big Money Loads Up
Remitly Global stock is in a buy zone above a cup-with-handle base as lawmakers ease remittance tax for certain money transfers.
Two Lagging Sectors Could Outperform in the Second Half of 2026
Financials and healthcare have underperformed the S&P 500 year to date, but the sectors might be set for a second half catch up. Truist CIO Keith Lerner upgraded the financials and healthcare sectors ...
3 Reasons to Sell PAG and 1 Stock to Buy Instead
Since July 2021, the S&P 500 has delivered a total return of 74.3%. But one standout stock has more than doubled the market - over the past five years, Penske Automotive Group has surged 158% to $200. ...
Flywire Stock Jumps 32.6% YTD: Is it Still a Buy or Better to Hold?
FLYW's 2026 rally reflects surging revenue, payment volume and margins, but its premium valuation makes holding more prudent than chasing the stock.
Has the AI Rally Made S&P 500 ETFs Too Risky? What Investors Need to Know
The artificial intelligence (AI) boom helped many investors generate huge profits. But there are two risks in particular that investors need to consider right now.
Eye drug developer Tarsier upsizes IPO seeking nearly $50M